American International Group (AIG)
NYSEFinancialsInsurance - DiversifiedSnapshot 2026-07-07
$81.06+0.38%
Close 2026-07-07 · 1-day change
Reading AIG? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track AIG free→NYSEFinancialsInsurance - DiversifiedSnapshot 2026-07-07
Reading AIG? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track AIG free→QuarterlyIQ Insights · AIG
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $81.06. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $81 AIG trades at 1.1× p/b, below its 2.1× p/b peer median. Our $94 fair value sits above the price. We hold it with low confidence: our number sits above the analyst range and the peer anchor overstates how cheap it looks. Analysts target $80–$88. Note: our $94 fair value sits above the entire analyst range ($80–$88). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $83.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $75.63 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $71.57 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $9.77 | — | — | TTM | high |
| graham number | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$80.00 – $88.00 (median $83.00) · 3 analysts · as of 2026-07-06
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $117.65 |
| — |
| — |
| TTM |
| high |
| Peer P/B | 12M | $156.45 | 2.1 | 74.57 | TTM | high |
| Peer P/FCF | 12M | $88.45 | 13.6 | 6.50 | TTM | high |
| Peer P/E | 12M | $136.52 | 16.5 | 8.25 | TTM | high |
| Peer P/S | 12M | $165.82 | 3.4 | 49.14 | TTM | high |
| PEG | 12M | $83.01 | 10.1 | 8.25 | TTM | high |
| residual income | 12M | $84.28 | — | — | TTM | high |
| Own P/E history | 12M | $76.45 | 9.3 | 8.25 | TTM | high |
| triangulated | 12M | $142.27 | 16.5 | 8.60 | Triangulated | high |
| Peer P/B | 3Y | $136.60 | 2.1 | 65.11 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $67.58 | 13.6 | 4.97 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $177.00 | 16.5 | 10.70 | Analyst | medium |
| Peer P/S | 3Y | $236.74 | 3.4 | 70.16 | Analyst | medium |
| PEG | 3Y | $107.61 | 10.1 | 10.70 | Analyst | medium |
| Own P/E history | 3Y | $99.12 | 9.3 | 10.70 | Analyst | medium |
| Peer P/B | 5Y | $124.78 | 2.1 | 59.47 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $56.47 | 13.6 | 4.15 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $223.28 | 16.5 | 13.49 | Analyst | high |
| Peer P/S | 5Y | $298.65 | 3.4 | 88.50 | Analyst | high |
| PEG | 5Y | $135.76 | 10.1 | 13.49 | Analyst | high |
| Own P/E history | 5Y | $125.03 | 9.3 | 13.49 | Analyst | high |